Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine. [electronic resource]
Producer: 20040316Description: 665-8 p. digitalISSN:- 0959-4973
- Aged
- Antineoplastic Agents -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Deoxycytidine -- adverse effects
- Female
- Gefitinib
- Hemolytic-Uremic Syndrome -- chemically induced
- Humans
- Lung -- diagnostic imaging
- Lung Neoplasms -- drug therapy
- Quinazolines -- adverse effects
- Tomography, X-Ray Computed
- Gemcitabine
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.